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Morton Neuroma: Evaluated with
Ultrasonography and MR Imaging
Objective: The purpose of this study was to compare the diagnostic accuracy
of both ultrasonography (US) and magnetic resonance imaging (MRI) for the
assessment of Morton neuroma.
Materials and Methods: Our study group was comprised of 20 neuromas from
17 patients, and the neuromas were confirmed on surgery following evaluation
with US, MRI, or both US and MRI. The diagnostic criterion for Morton neuroma,
as examined by US, was the presence of a round or ovoid, well-defined, hypoe-
choic mass. The diagnostic criterion, based on MR imaging, was a well defined
mass with intermediate to low signal intensity on both the T1- and T2-weighted
images. The retrospective comparison between the sonographic and MR images
was done by two experienced radiologists working in consensus with the surgical
and pathologic correlations. 
Results: The detection rate of Morton neuroma was 79% for 14 neuromas from
11 patients who had undergone US followed by an operation. The detection rate
was 76% for 17 neuromas from 15 patients who had undergone MRI and a sub-
sequent operation. The mean size of the examined neuromas was 4.9 mm on the
US images and it was 5.1 mm on the MRI studies. Ten neuromas (71%) were 5
mm or less as measured by US, and three neuromas were not detected, whereas
on the MRI analysis, 10 neuromas (59%) were 5 mm or less and four neuromas
were not visualized. Among the patients examined during postoperative follow-
up, symptoms were completely relieved in 85% and the symptoms were partially
relieved in 15%.
Conclusion: US and MR imaging are comparable modalities with high detec-
tion rate for the evaluation of Morton neuroma. 
orton neuroma is a nonneoplastic condition characterized by neural
degeneration and perineural fibrosis of the plantar nerve (1). This
condition is a common cause of forefoot pain, especially in middle-aged
women who frequently wear fashionable, high-heeled shoes that are not designed for
the normal physiology of the foot (2). Previous studies have reported the prevalence
of Morton neuroma to be about 30 33% (3, 4). Most neuromas are located in the
second or third intermetatarsal space and they produce symptoms when they have
reached a diameter of at least 5 mm (3 6). 
Prior to surgical removal, the exact localization as well as the accurate diagnosis of
Morton neuroma is prerequisite. Although clinical assessment can be accurate for the
diagnosis of Morton neuroma, magnetic resonance imaging (MRI) and ultrasonography
(US) have advantages for determining its localization (7, 8). Zanetti et al. showed that
MR imaging has a major effect on the diagnosis and the therapeutic decisions by
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orthopedic surgeons when Morton neuroma is suspected
because MR imaging helps in determining the location and
size of Morton neuroma (8). Both the US and MRI modali-
ties have demonstrated sensitivities of 87 98% for the
diagnosis of Morton neuroma (1, 5, 6, 9, 10).
There are few clinical studies that have performed both
US and MRI for the assessment of Morton neuroma. In one
study (11), neither modality was reported to be beneficial
for the detection of Morton neuroma. However, the
authors of that study did not fully discuss the drawbacks of
the lack of the specificity when surgically confirmed
neuromas were exclusively included in the study without a
control group. They also stated that the pain caused by the
neuroma was not size-dependent, which could be a contro-
versial finding (3 6).
In addition, fat-suppressed T1-weighted imaging after
intravenous injection of gadolinium contrast is part of our
institute’s routine protocol for examining potential Morton
neuromas. In our experience with interpreting Morton
neuroma, we consider that the use of contrast enhanced
T1-weighted imaging is equivocal. To the best of our
knowledge, there has been only one published report
showing that the contrast-enhanced fat-suppressed image
significantly increased lesion conspicuity (12). However,
other investigations did not demonstrate any superiority of
the contrast enhanced sequence (1, 13).
Hence, the purpose of this study is to evaluate the
diagnostic accuracy of US and MRI for detecting Morton
neuroma, and to evaluate whether or not the gadolinium
contrast enhanced T1-weighted image increases the
conspicuity of the lesion.
MATERIALS AND METHODS
Patients
From March 2001 to February 2005, we performed US
in 58 patients, MRI in 24 patients, and both MRI and US in
10 patients for a total of 72 patients (63 women and 9
men, age range: 19 70 years, average age: 50 years) who
were clinically suspected of having Morton neuroma. By
review of the pathologic and surgical reports on the
medical records, the final study group of this report was
comprised of twenty confirmed Morton neuromas in 17
patients among the 72 patients: 12 neuromas (in 11
patients) were pathologically confirmed by partial neurec-
tomy; the remaining eight neuromas (in 6 patients) were
confirmed by gross inspection at the time of surgery, and
these were remedied by neurolysis. 
Surgical Data and Assessing the Therapeutic Outcome
All the surgery was performed by one experienced
orthopedic surgeon. The surgical decision for surgery was
based on the clinical findings and the pre-operative MRI
and/or US reports. Therapeutic success was assessed at the
post-operative, 2-month follow-up. Patients were asked to
access their satisfaction with the operation results accord-
ing to the system advocated by Johnson et al. (14) as
follows: 1) Completely satisfied (essentially pain free, no
restrictions in activity and only minor restrictions in
footwear), 2) Satisfied with minor reservations (occasional
mild pain, minor restrictions in activity and minor restric-
tions in foot wear), 3) Satisfied with major reservations
(mild or moderate pain, moderate restrictions in activity
and major restrictions in footwear, but overall improve-
ment), 4) Dissatisfied (no improvement in pain or worse
pain, major restrictions in activity and footwear, or worse
symptoms).
The grades of the patients’ satisfaction and the difference
of the grades according to the methods of treatment were
analyzed.
Imaging Protocols, Diagnostic Criteria and Analysis of
the Imaging Findings
The US evaluation was performed by one of four experi-
enced musculoskeletal radiologists with using 9-MHz linear
array transducers (HDI 5000, Advanced Technology
Laboratories, Bothell, WA). The US images were obtained
from the plantar aspect of the foot in the transverse and
longitudinal planes, relative to the metatarsal shafts, with
each patient in a sitting position with their feet in slight
plantar flexion. The diagnostic criterion for Morton
neuroma, as assessed by US, was a well-defined, round or
ovoid, hypoechoic (relative to the adjacent muscle) mass
located just proximal to the metatarsal heads in the plantar
aspect of the intermetatarsal space (5). 
All the MR imaging studies were performed on a 1.5-T
scanner (Signa Horizon, GE Medical Systems, WI). The
patients were examined in the supine position with the
foot placed in plantar flexion within a transmit-receive
extremity coil. The imaging protocol consisted of a T1-
weighted spin-echo sequence (T1WI; TR/TE, 550/9), a fast
spin echo (FSE) T2-weighted sequence (T2WI; TR/TE,
4000/96) and a T1-weighted fat-suppressed spin-echo
sequence (contrast-enhanced fat-saturated [CEFS] T1WI;
TR/TE, 617/12) that was obtained after the intravenous
injection of 0.2 ml/kg gadopentetate (Magnevist, Schering,
Berlin, Germany). The imaging plane was oblique coronal,
and this was perpendicular to the metatarsal bones. The
section thickness was 3 5 mm without an intersection gap,
the image matrix was 256 192 or 256 256 and the field
of view was 10 14 cm (mostly 12 cm); this resulted in in-
plane resolution of 0.220 0.292 mm2 (pixel size). The
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diagnostic criterion for MR imaging was a well-demarcated
ovoid or dumbbell-shaped intermetatarsal mass at the
plantar aspect near the metatarsal heads, and the mass had
intermediate to low signal intensity on both T1WI and
T2WI (1, 15, 16). 
The comparison of the US and MR imaging findings was
performed retrospectively by a consensus of two experi-
enced radiologists, and then each image was correlated
with the surgical and pathologic findings. The size of the
lesion was measured as the largest transverse diameter on
both US and MRI. The fluid between the metatarsal bones
(the inter-metatarsal bursa) was excluded during the
measurement of the lesion on MRI. In addition, we
compared the T1WI with the CEFS T1WI for lesion
conspicuity and for detecting Morton neuroma. 
RESULTS
Surgical Data and Assessment of the Therapeutic
Outcome
Among the 20 neuromas (in 17 patients), 12 neuromas
(12/20, 60%) were found in the third intermetatarsal space
and the other eight neuromas (8/20, 40%) were in the
second intermetatarsal space (Table 1) upon operation.
Therapeutic success was assessed at the post-operative 2-
month follow-up in 13 patients because four patients who
underwent excision were unfortunately lost during follow
up. Eleven out of the 13 patients (11/13, 85%) had near
complete relief from pain, two (2/13, 15%) had moderate
improvement with some remaining pain, and none of the
patients became worse. Complete relief or marked
improvement of the pain was seen in six patients (6/7,
86%) treated by excision and in five patients (5/6, 83%)
treated by neurolysis (Table 1).
General Information and the Result of Imaging
Analysis
Among the confirmed 20 Morton neuromas (in 17
patients), US was performed for 14 neuromas (11
patients), MRI was performed for 17 neuromas (15
patients), and both US and MRI were performed for 11
neuromas (9 patients). The typical appearance of Morton
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Table 1. US and MRI Findings Correlated with Treatment and the Clinical Outcome
Operation Patient Operation US Finding MRI Finding Better MR Clinical
Name No. Gender Age Site (size, mm) (size, mm) Sequence Visualizing Outcome(web space) Neuroma
Excision 1 F 56 left 2nd mass (4) mass (4) T1WI 3
2 F 43 left 3rd mass (6) T1WI 3
3 F 59 right 3rd * FL
4 F 43 left 3rd mass (4) T1WI FL
5 M 19 right 3rd mass (5) ND 2
6 F 63 right 2nd mass (5) FL
7 F 46 left 2nd mass (4) mass (5) ND FL
8 F 49 left 3rd mass (5) 4
9 F 55 right 3rd mass (5) 4
left 3rd mass (5) mass (5) ND
10 F 46 left 3rd mass (5) mass (5) ND 4
11 F 67 left 2nd mass (4) mass (4) ND 4
Neurolysis 12 M 37 left 3rd * 4
13 F 66 right 2nd mass (9) mass (8) ND 3
right 3rd mass (5) ND
14 F 43 right 2nd mass (4) * 3
15 F 31 right 3rd mass (7) ND 4
16 F 55 left 2nd mass (5) ND 3
left 3rd mass (4) *
17 F 48 right 2nd mass (3) CE-FS 2
Note. = the patients who underwent operation at 2 sites,
= not visualized (false negative),
= not done, 
ND = no difference,
clinical outcome : 4, completely satisfied; 3, satisfied with minor reservation; 2, satisfied with major reservation; 1 dissatisfied; FL, follow-
up loss.
neuroma on the US and MR images is shown in Figure 1.
US depicted 11 out of 14 neuromas correctly, but the
remaining three neuromas were not detected. Hence, the
detection rate of US was 79% (11/14). On the other hand,
MRI detected 13 out of 17 neuromas correctly, but the
remaining four neuromas were not detected. Hence, the
detection rate of MRI for Morton neuroma was 76%
(13/17).
Figure 2 shows the true positive and false negative
lesions in the patients who underwent both US and MR
imaging. US demonstrated a mass in only the third
intermetatarsal space, while the MR imaging revealed a
mass in only the second intermetatarsal space.
Three patients had false negative results on the US
imaging analysis, and four patients had false negative
results on the MRI analysis (Table 1). Among them, five
patients underwent neurolysis and only one patient
underwent excision. Figure 3 shows the case confirmed by
excision and pathologically proven, but it was false
negative on MR. 
On US, the mean size of the measured neuromas was 4.9
1.45 mm (range: 4 9 mm). On MRI, the mean size of
the neuroma was 5.1 1.32 mm (range: 3 8 mm). Most of
the neuromas were 5 mm or less (10 of the 14 neuromas
[71%] detected on US and 10 of the 17 neuromas [59%]
detected on MRI). The maximum difference in size for the
same masses measured by US and MR imaging was less
than 1 mm.
Of the 13 neuromas depicted by MR imaging, three were
visualized only on T1WI, while one was noted only on the
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Fig. 1. Morton neuroma in the second intermetatarsal space in a
56-year-old woman (patient number 1 in table 1). She experienced
pain in the second intermetatarsal space on the left foot. 
A, B. Sonogram of the second intermetatarsal space in the coronal
plane shows a 4 mm-sized, ovoid, hypoechoic nodule (arrow)
between the 2nd and 3rd metatarsal heads. 
C. The T1-weighted spin-echo MR image (TR/TE = 550/9) shows a
well-demarcated 5-mm-sized, hypo-intense soft-tissue nodule
(arrow) in the second intermetatarsal space. 
D. The FSE T2-weighted MR image (TR/TE = 4000/96) shows
areas of slightly increased signal intensity within the neuroma
(arrow). 
E. The T1-weighted fat-suppressed contrast-enhanced spin-echo
MR image (TR/TE = 617/12) shows mild enhancement in the
nodule (arrow).
E
CEFS T1WI. The remaining nine neuromas were detected
on both sequences. Accordingly, the neuromas detected on
T1WI (12/13, 92%) outnumbered those on the contrast-
enhanced images (10/13, 77%) (Table 1). 
DISCUSSION
Morton neuroma was first described by Thomas Morton
in 1876 as “a peculiar and painful affection of the fourth
metatarsophalangeal articulation” (17). However,
subsequent studies have shown that the third and second
spaces are the more common sites for neuroma (5). Our
study has also demonstrated that the third space is the
most common site of involvement.
The exact pathogenesis of Morton neuroma remains
controversial. It is generally accepted that the development
of Morton neuroma may be induced by repetitive
compression of the plantar nerve against the deep
transverse intermetatarsal ligament, with subsequent
perineural fibrosis (18). 
A tentative diagnosis of Morton neuroma can be made at
the time of clinical assessment, but imaging correlation is
Lee et al.
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Fig. 2. Morton neuroma in the second and third intermetatarsal
spaces in a 55-year-old woman (patient number 16 in table 1). The
patient had suffered from metatarsalgia in the third intermetatarsal
space on the left foot.
A, B. The sonogram of the third intermetatarsal space in the
sagittal (A) and coronal (B) planes shows a 4 mm-sized, ovoid,
hypoechoic nodule (arrows) in the 3rd intermetatarsal space. No
abnormal lesion is seen in the second space. 
C. Instead, the T1-weighted spin-echo MR image (TR/TE = 550/9)
shows a well-demarcated, 5 mm-sized, hypointense soft-tissue
nodule (arrow) in the second intermetatarsal space. 
D. The FSE T2-weighted MR image (TR/TE = 4000/96) shows
hyperintensity within the neuroma (arrow). 
E. The T1-weighted fat-suppressed contrast-enhanced spin-echo
MR image (TR/TE = 617/12) shows homogeneous enhancement
of the nodule (arrow). No abnormal finding is seen in the third
intermetatarsal space. At operation, both the 2nd and 3rd plantar
nerves were thickened and neurolysis was performed on these two
nerves. The patient s pain was relieved after the operation.
E
required for the exact localization of neuroma and for the
detection of multiple lesions, and especially when the
clinical findings are indeterminate. This can prevent
patients from undergoing rather avoidable surgical
exploration at the wrong sites, which may lead to inadver-
tent complications (5, 17). In addition, other causes of
metatarsalgia can also be excluded via imaging modalities.
The possible clinical differential diagnoses that can cause
metatarsalgia include intermetatarsal bursitis, stress
fractures, necrosis of the sesamoid bones, synovitis of the
metatarsophalangeal joint, infection and true neoplasm (3,
8). 
Some differential diagnoses should be considered during
the imaging analysis. These include intermetatarsal bursitis,
ganglion cyst, synovial cyst, giant cell tumor (GCT) of the
adjacent tendon sheath, fibromatosis, nodular fasciitis,
pigmented villonodular synovitis and physiologic fluid
distention of the intermetatarsal bursa when examining by
using US and MRI (4, 17). An investigation using US
suggested that if a mass in the interdigital space is greater
than 20 mm in length, then it is an abnormality other than
neuroma such as a ganglion cyst, a synovial cyst or a GCT
of the adjacent tendon sheath (17).
Several sonographic study results have disclosed a
prospective sensitivity of 95 98% for Morton neuromas
and a retrospective sensitivity of up to 100% (5, 6, 9).
However, a recent study by Quinn et al. (17) revealed that
85% of neuromas with an average width of 6 mm, an
average height of 9 mm and an average length of 13 mm
were identified prospectively. Analysis by US in our study
showed a relatively low detection rate (79%) of Morton
neuroma. There are multiple reasons for the various
reported detection rates with using sonography.
Sonography is a very operator-dependent technique, for
instance, the sonographer’s experience is quite important,
and so erroneous detection does factor into US examina-
tions. The size of the Morton neuroma is considered as
another factor contributing to the variability of detection.
The diameter of the normal plantar digital nerve is 1 2
mm at the level of the intermetatarsal heads and the
normal nerve is not readily identifiable on sonography (5,
9). In our study, the mean sizes of the masses were 4.9 mm
with using US and 5.1 mm with using MRI, and these
values were smaller than those reported in a previous
study (6.5 mm for US and 7.4 mm for MRI) (11).
MR imaging is a highly sensitive modality (87%) for the
detection of Morton neuroma (1). Our MR imaging evalua-
tion (detection rate: 76%) did not show a better detection
result than that expected at the beginning of the study.
Four out of 17 neuromas were not detected. In these cases,
two neuromas were as small as 4 mm in transverse
diameter (one of these is the case presented in Figure 2).
That these lesions were missed was possibly due to their
smaller size, and it was possibly due to the surgeon’s
Imaging Findings of Morton Neuroma
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Fig. 3. Morton neuroma in the third intermetatarsal space in a 59-
year-old woman (patient number 3 in table 1). Only MRI was
performed. 
A. The T1-weighted spin-echo MR image (TR/TE = 483/11) shows
a well-demarcated, 5 mm-sized, hypointense soft-tissue nodule
(arrow) in the second intermetatarsal space. 
B. The FSE T2-weighted MR image (TR/TE = 5400/96) shows
areas of slightly increased signal intensity within the neuroma
(arrow). 
C. The T1-weighted fat-suppressed contrast-enhanced spin-echo
MR image (TR/TE = 683/11) shows mild enhancement of the
nodule (arrow). An operation was performed on only the 3rd
intermetatarsal space because of metatarsalgia in this area, and a
thick 1-cm-sized neuroma was excised. The second
intermetatarsal space was not confirmed as containing neuroma
during the operation. 
C
subjective diagnosis in the cases of surgical neurolysis in
our study.
We should again consider the matter of the lesions’ size.
In our study, most of the neuromas that were operated
upon were 5 mm or less. There was no lesion less than 3
mm detected by either the US or MRI modalities. In this
aspect, the size of the lesions that were operated in our
study was relatively smaller as compared with previous
studies (1, 3, 7, 17). The measurement of Morton neuroma
on the transverse MR image is dependent on the placement
of the foot in the scanner. In addition, the size of the
Morton neuroma is significantly larger in the prone
position with plantar flexion of the ankle than in the supine
and upright weight-bearing positions, in which the ankle is
dorsiflexed (15). Our study was done with the foot placed
in the supine position, which possibly caused a decreased
diameter of the neuroma, although plantar flexion was
applied to the ankle. Furthermore, sonographic measure-
ment and patient position are examiner-dependent. The
transverse diameter can be affected by the patient’s
position or by the compression pressure during sonogra-
phy.
Previous studies have demonstrated that neuromas
larger than 5 mm in diameter are more symptomatic than
the smaller ones (3, 5, 6). Biasca et al. (7) showed that a
more favorable clinical outcome can be expected after
surgical intermetatarsal neurectomy when a Morton
neuroma has a transverse measurement larger than 5 mm
on MRI scans; 77% of the patients in that study had a good
outcome when the neuroma was greater than 5 mm,
compared with only 17% of the patients had a good
outcome when their neuromas measured 5mm or less. On
the other hand, Sharp et al. (11) demonstrated that
symptoms were not dependent on the size of the neuroma.
Moreover, the MR imaging diagnosis of Morton neuroma
does not always imply symptomatology; thus, careful
correlation between the clinical and MR imaging findings is
mandatory (4). The fluid distention of the intermetatarsal
bursa may mimic that of neuromas, but it may not manifest
symptoms and it is typically less than 3 mm in transverse
dimension (3).
There are different opinions regarding the best MR
imaging sequences for detecting Morton neuroma (12, 15,
16). Erickson et al. (16) reported that T1WI was the most
useful sequence because neuromas with decreased signal
intensity were well demarcated from the adjacent fat
tissue. On the other hand, Zanetti et al. (3) suggested that
T2WI was beneficial in order to exclude other diseases that
mimic neuroma, such as intermetatarsal bursitis, because
the latter revealed high signal intensities. Terk et al. (12)
stressed that sequences with fat-suppression and contrast-
enhancement were reliable sequences for showing high-
contrast images, and their study revealed that T1WI alone
failed to demonstrate the presence of 50% (3 of 6) of the
neuromas. In our study, the T1WI revealed better results
for the detection of Morton neuroma than the CEFS T1WI
did. In particular, the rarely enhanced neuroma cases
shown in Figures 1 and 3 were better discriminated on
T1WI than on CEFS T1WI. However, the opposite was
also true in Figure 2 when the neuroma was well
enhanced. We think that CEFS T2WI is not obligatory for
the purpose of detection alone, although it can be
necessary for differentiation of neuroma from other
possible lesions.
There are several limitations in our study. The false-
positive and true-negative rates could not be obtained
because our study group consisted of only surgically
proven Morton neuromas (including cases of neurolysis
that might have been related to the surgeon’s subjectivity).
In addition, performing surgical exploration in the
asymptomatic intermetatarsal spaces in clinical settings is
not ethically possible whether or not a suspected Morton
neuroma is found on imaging studies. The second limita-
tion is the retrospective analysis of the US findings, is that,
sonography is an operator-dependent method. The third
limitation is that the double lesions in one patient were not
separately evaluated in the clinical outcome. 
In summary, US and MR imaging are compatible modali-
ties for the evaluation of Morton neuroma, and both
modalities have relatively high detection rates. Both
imaging studies can provide information on the location
and size of the neuroma prior to surgery. In addition, the
contrast enhanced sequence does not seem essential for the
detection of neuroma. 
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